Kentaro Ikeya

876 total citations
15 papers, 354 citations indexed

About

Kentaro Ikeya is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Kentaro Ikeya has authored 15 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 8 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Kentaro Ikeya's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (6 papers) and Mycobacterium research and diagnosis (3 papers). Kentaro Ikeya is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (6 papers) and Mycobacterium research and diagnosis (3 papers). Kentaro Ikeya collaborates with scholars based in Japan. Kentaro Ikeya's co-authors include Hiroyuki Hanai, Ken Sugimoto, Takayuki Iida, Yasuhiko Maruyama, Fumitoshi Watanabe, Satoshi Osawa, Shinya Tani, Satoshi Tamura, Ryosuke Takano and Masami Yamada and has published in prestigious journals such as Gastroenterology, PLoS ONE and Digestive Diseases and Sciences.

In The Last Decade

Kentaro Ikeya

15 papers receiving 346 citations

Peers

Kentaro Ikeya
Xue-Liang Jiang China
Kindra Clark‐Snustad United States
Silvia Bakos Austria
Matthew C. Choy Australia
I. Guadagni Italy
Valeria Criscuoli Italy
Juan S. Lasa Argentina
Laura Rosenberg United States
Manabu Shiraki Japan
Talia Zenlea United States
Xue-Liang Jiang China
Kentaro Ikeya
Citations per year, relative to Kentaro Ikeya Kentaro Ikeya (= 1×) peers Xue-Liang Jiang

Countries citing papers authored by Kentaro Ikeya

Since Specialization
Citations

This map shows the geographic impact of Kentaro Ikeya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Ikeya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Ikeya more than expected).

Fields of papers citing papers by Kentaro Ikeya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Ikeya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Ikeya. The network helps show where Kentaro Ikeya may publish in the future.

Co-authorship network of co-authors of Kentaro Ikeya

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Ikeya. A scholar is included among the top collaborators of Kentaro Ikeya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Ikeya. Kentaro Ikeya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sugimoto, Ken, Kentaro Ikeya, Ryosuke Takano, et al.. (2021). Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease. PLoS ONE. 16(7). e0254548–e0254548. 3 indexed citations
2.
Sugimoto, Ken, Kentaro Ikeya, Shigeki Bamba, et al.. (2020). Highly Bioavailable Curcumin Derivative Ameliorates Crohn’s Disease Symptoms: A Randomized, Double-Blind, Multicenter Study. Journal of Crohn s and Colitis. 14(12). 1693–1701. 54 indexed citations
3.
Sugimoto, Ken, Kentaro Ikeya, Shigeki Bamba, et al.. (2019). Tu1716 – Highly Bioavailable Curcumin (Theracurmin®) for Crohn's Disease: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial. Gastroenterology. 156(6). S–1096. 3 indexed citations
4.
Sugimoto, Ken, Kentaro Ikeya, Shigeki Bamba, et al.. (2019). Highly Bioavailable Curcumin Derivative 'Theracurmin®' for Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Multicentre Study. SSRN Electronic Journal. 2 indexed citations
5.
Sugimoto, Ken, Kentaro Ikeya, Fumitoshi Watanabe, et al.. (2018). Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice. Digestive Diseases. 37(1). 11–20. 4 indexed citations
6.
Yamamoto, Takayuki, Takayuki Iida, Kentaro Ikeya, et al.. (2018). A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. Clinical and Translational Gastroenterology. 9(7). e170–e170. 19 indexed citations
7.
8.
Ikeya, Kentaro, Hiroyuki Hanai, Ken Sugimoto, et al.. (2015). The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score. Journal of Crohn s and Colitis. 10(3). 286–295. 127 indexed citations
9.
Sugimoto, Ken, Kentaro Ikeya, Takayuki Iida, et al.. (2015). An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn’s Disease. Digestive Diseases and Sciences. 61(1). 99–106. 9 indexed citations
10.
Ikeya, Kentaro, Ken Sugimoto, Takayuki Iida, et al.. (2015). Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis. Digestive and Liver Disease. 47(5). 365–371. 31 indexed citations
11.
Iida, Takayuki, Kentaro Ikeya, Fumitoshi Watanabe, et al.. (2013). Looking for Endoscopic Features of Cytomegalovirus Colitis. Inflammatory Bowel Diseases. 19(6). 1156–1163. 36 indexed citations
12.
Ikeya, Kentaro, Satoshi Osawa, Yasushi Hamaya, et al.. (2012). Decompression side tube-equipped double-balloon enteroscopy extends intubation depth and reduces patient discomfort. Endoscopy. 44(S 02). E256–E257. 4 indexed citations
13.
Hanai, Hiroyuki, Takayuki Iida, Kentaro Ikeya, et al.. (2012). A new paradigm in ulcerative colitis: Regulatory T cells are key factor which induces/exacerbates UC through an immune imbalance. Molecular Immunology. 54(2). 173–180. 11 indexed citations
14.
Hanai, Hiroyuki, Takayuki Iida, Ken Takeuchi, et al.. (2008). Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: An unblinded randomised multi-centre controlled study. Digestive and Liver Disease. 40(6). 433–440. 36 indexed citations
15.
Ikeya, Kentaro, et al.. (1998). [Effects of lactated Ringer solution and acetated Ringer solution on hepatic ATP and L/P ratio in rats subjected to acute hemorrhage].. PubMed. 47(1). 36–41. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xue-Liang Jiang Breakdown of academic impact, for papers by Kindra Clark‐Snustad Breakdown of academic impact, for papers by Silvia Bakos Breakdown of academic impact, for papers by Matthew C. Choy Breakdown of academic impact, for papers by I. Guadagni Breakdown of academic impact, for papers by Valeria Criscuoli Breakdown of academic impact, for papers by Juan S. Lasa Breakdown of academic impact, for papers by Laura Rosenberg Breakdown of academic impact, for papers by Manabu Shiraki Breakdown of academic impact, for papers by Talia Zenlea
Rankless by CCL
2026